首页> 外文期刊>Foundations and trends in systems and control >Cost Analysis of Biliary Drainage Using Metal versus Plastic Stents in Hepatocellular Carcinoma Patients with Obstructive Jaundice
【24h】

Cost Analysis of Biliary Drainage Using Metal versus Plastic Stents in Hepatocellular Carcinoma Patients with Obstructive Jaundice

机译:使用金属与塑料支架对肝细胞癌患者进行阻塞性黄疸患者的成本分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The optimal method of biliary drainage for biliary obstruction caused by hepatocellular carcinoma (HCC) is controversial, and the possible endoscopic application of plastic and metal stents is the least invasive procedure to improve patients' quality of life. Aim: Our objective was to study cost evaluation based on a clinical efficacy of both procedures in a randomized trial comparing both approaches in patients with biliary obstruction caused by HCC. Methods: The strategy of management was based on clinical effectiveness of biliary drainage with either metal or plastic stents in 90 patients over a 1-year follow-up period. Total (direct and indirect) costs were evaluated. Results: The direct costs were EGP 40,857.84 and 21,802.62 per patient with plastic and metal stents, respectively. Concerning the indirect costs, EGP 888 and 454 were spent for each patient with plastic and metal stents, respectively. The differences in the costs resulted from patients with plastic stent insertion requiring more second endoscopic retrograde cholangiopancreatography procedures and more medication, medical consultation, and hospitalization during the year of follow-up. Conclusions: Based on this analysis, the use of metal stents rather than plastic stents in biliary drainage is more cost effective for this group of patients.
机译:背景:胆道引流的优化方法对胆道梗阻引起的肝细胞癌(HCC)是有争议的,可能的塑料和内窥镜的应用程序金属支架是最侵入性程序提高病人的生活质量。目的是研究基于成本评估在临床疗效的过程随机试验比较两种方法胆道梗阻患者肝癌引起的。方法:战略管理是基于胆道引流的临床效果金属或塑料支架90例1年随访期间。间接成本进行评估。直接成本是出路40857 .84 21802 .62点塑料和金属支架,患者分别。888年和454年是为每个病人度过的塑料和金属支架,分别。成本的差异导致病人用塑料支架插入需要更多第二个内镜逆行胆管造影程序和更多药物、医疗咨询、和住院期间一年的随访。结论:在此基础上分析的使用金属支架,而不是塑料支架胆道引流更符合成本效益组患者。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号